Metabolomic Profiling to Identify Molecular Biomarkers of Cellular Response to Methotrexate In Vitro

by Ryan S. Funk, Rakesh K. Singh, Mara L. Becker
Published 2020-01-01

Factors associated with reduced infliximab exposure in the treatment of pediatric autoimmune disorders: a cross-sectional prospective convenience sampling study

by Ryan S. Funk, Valentina Shakhnovich, Yu Kyoung Cho, Kishore Polireddy, Taina Jausurawong, Kyle Gress, Mara L. Becker
Published 2021-05-01

Facing Real-World Challenges of Immunogenicity in Pediatric Inflammatory Bowel Disease

by Kyle Gress, Julie A. Bass, Julie A. Bass, Ryan S. Funk, Ryan P. Morrow, Ryan P. Morrow, Rachel Hasenkamp, Valentina Shakhnovich, Valentina Shakhnovich
Published 2020-06-01

Immunogenicity in Clinical Practice and Drug Development: When is it Significant?

by Valentina Shakhnovich, Bernd Meibohm, Amy Rosenberg, Andrzej M. Kierzek, Rachel Hasenkamp, Ryan S. Funk, Craig J. Thalhauser, Piet H. van derGraaf, Yow‐Ming C. Wang, Lora Hamuro
Published 2020-03-01

Leveraging innovative technology to generate drug response phenotypes for the advancement of biomarker‐driven precision dosing

by Akinyemi Oni‐Orisan, Nithya Srinivas, Krina Mehta, Jesmin Lohy Das, Thu T. Nguyen, Geoffrey H. Tison, Scott R. Bauer, Maria Burian, Ryan S. Funk, Richard A. Graham, Biomarkers and Translational Tools Community Working Group of the American Society for Clinical Pharmacology and Therapeutics
Published 2021-05-01

Reducing Heart Dose with Protons and Cardiac Substructure Sparing for Mediastinal Lymphoma Treatment

by Kekoa Taparra, MD, PhD, Scott C. Lester, MD, W. Scott Harmsen, MS, Molly Petersen, Ryan K. Funk, MD, Miran J. Blanchard, MD, Phillip Young, MD, Joerg Herrmann, MD, Ashley Hunzeker, CMD, Heather Schultz, CMD, RTT, Cynthia McCollough, PhD, Alexandria Tasson, PhD, Shuai Leng, PhD, James A. Martenson, MD, Thomas J. Whitaker, PhD, Eric Williamson, MD, Nadia N. Laack, MD
Published 2020-09-01